Company research

Explore company profiles, quarterly results, announcements and ownership disclosures.

Loading the company view…

Max Healthcare Institute Limited (MAXHEALTH) — Stock Analysis

Max Healthcare Institute Limited (NSE: MAXHEALTH), ISIN INE027H01010 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.

MAXHEALTH last traded at ₹1052.55 (+0.32%), with a 52-week range of ₹903.50 to ₹1221.10 (as of 23 Sep 2026).

Shareholding as of Jun 2026: promoters 23.71%, FIIs 41.78%, DIIs 29.96%, mutual funds 18.68%.

EquiSense Score (ECS): 78/100.

Data sourced from NSE and BSE filings. Educational — not investment advice.